Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  graft versus host disease
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-25 of 56 for your search:
Start Over
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: BMTCTN0801, U01HL069294, U01HL069294-06, NCT01106833
Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 1 to 29
Sponsor: NCI, Other
Protocol IDs: ASCT0031, COG-ASCT0031, CCG-S9701, NCI-P02-0213, NCT00031824
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to under 22 at first relapse
Sponsor: NCI, Other
Protocol IDs: ASCT0431, NCI-2009-01068, CDR0000500131, COG-PBMTC-ONCO51, COG-ASCT0431, U10CA098543, NCT00382109
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 2 to 55
Sponsor: NCI, Other
Protocol IDs: 385, U01HL069294, BMT CTN 0402, U01 HL069294-05, NCT00406393
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: VICC BMT 0766, P30CA068485, VU-VICC-BMT-0766, VU-080786, NCT00755040
Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000269672, DFCI-99279, RPCI-DS-0218, ROCHE-RPCI-DS-0218, NCT00053976
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 669, U01HL069294, BMT CTN 0802, U01 HL069294-06, NCT01002742
Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2327.00, NCI-2010-00323, P01CA018029, NCT00929695
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 5 to 75
Sponsor: NCI, Other
Protocol IDs: 1500.00, FHCRC-1500.00, RPCI-DS-99-27, NCI-H01-0067, CDR0000068475, NCT00010283
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: 1723.00, FHCRC-1723.00, CDR0000270397, NCT00054340
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1668.00, NCI-2012-00668, P30CA015704, P01CA018029, FHCRC-1668.00, NCT00078858
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: Per primary treatment protocol
Sponsor: NCI, Other
Protocol IDs: 1811.00, FHCRC-1811.00, CDR0000378004, NCT00089037
Phase II Study of Tacrolimus Based Immunosuppression for Prevention of Graft vs Host Disease (GVHD) After HLA Nonidentical Marrow or Blood Stem Cell Transplantation
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 12 to 50
Sponsor: NCI
Protocol IDs: MDA-DM-93120, NCI-G96-1007
Phase II Study of DCF in the Treatment of Patients with Acute Graft Versus Host Disease
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: specified in BMT protocols
Sponsor: NCI
Protocol IDs: EUC-14786, NCI-T86-0136O, T86-0136
Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000341678, U10CA031946, CALGB-100101, ECOG-1010, NCT00074035
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1898.00, NCI-2010-00267, P01CA078902, P30CA015704, FHCRC-1898.00, 5788, NCT00089011
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1938.00, NCI-2010-00268, P30CA015704, P01CA018029, FHCRC-1938.00, 5887, NCT00105001
Campath-1H + FK506 and Methylprednisolone for GVHD
Phase: Phase II
Type: Supportive care
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CASE1Z04, P30CA043703, CASE-CWRU-1Z04, CWRU-060419, NCT00109993
Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 10 and over
Sponsor: NCI, NHLBI
Protocol IDs: BMTCTN0302, U01HL069294-05, 285, JHOC-05040403, JHOC-J0519, NCT00224874
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 01089, P30CA033572, CHNMC-01089, CDR0000566376, NCT00544115
Start Over